Talis Biomedical Corp Stock Net Income
Talis Biomedical Corp fundamentals help investors to digest information that contributes to Talis Biomedical's financial success or failures. It also enables traders to predict the movement of Talis Pink Sheet. The fundamental analysis module provides a way to measure Talis Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Talis Biomedical pink sheet.
Talis |
Talis Biomedical Corp Company Net Income Analysis
Talis Biomedical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Talis Biomedical Net Income | (62.01 M) |
Most of Talis Biomedical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Talis Biomedical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Talis Biomedical Corp reported net income of (62.01 Million). This is 118.17% lower than that of the Health Care Equipment & Supplies sector and 126.04% lower than that of the Health Care industry. The net income for all United States stocks is 110.86% higher than that of the company.
Talis Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Talis Biomedical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Talis Biomedical could also be used in its relative valuation, which is a method of valuing Talis Biomedical by comparing valuation metrics of similar companies.Talis Biomedical is currently under evaluation in net income category among its peers.
Talis Fundamentals
Return On Equity | -0.7 | ||||
Return On Asset | -0.3 | ||||
Operating Margin | (113.60) % | ||||
Current Valuation | (38.24 M) | ||||
Shares Outstanding | 1.82 M | ||||
Shares Owned By Insiders | 8.30 % | ||||
Shares Owned By Institutions | 52.15 % | ||||
Number Of Shares Shorted | 17.96 K | ||||
Price To Book | 0.06 X | ||||
Price To Sales | 19.57 X | ||||
Revenue | 412 K | ||||
Gross Profit | (149.4 M) | ||||
EBITDA | (60.7 M) | ||||
Net Income | (62.01 M) | ||||
Cash And Equivalents | 165.37 M | ||||
Cash Per Share | 6.21 X | ||||
Total Debt | 19.67 M | ||||
Debt To Equity | 0.19 % | ||||
Current Ratio | 12.51 X | ||||
Book Value Per Share | 26.68 X | ||||
Cash Flow From Operations | (53.24 M) | ||||
Short Ratio | 0.59 X | ||||
Earnings Per Share | (28.02) X | ||||
Target Price | 5.0 | ||||
Number Of Employees | 99 | ||||
Beta | 1.62 | ||||
Market Capitalization | 7.98 M | ||||
Total Asset | 98.34 M | ||||
Retained Earnings | (539.96 M) | ||||
Working Capital | 68.91 M | ||||
Net Asset | 98.34 M |
About Talis Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Talis Biomedical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Talis Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Talis Biomedical Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Other Consideration for investing in Talis Pink Sheet
If you are still planning to invest in Talis Biomedical Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Talis Biomedical's history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Stocks Directory Find actively traded stocks across global markets | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |